TickerFacts.

Iridex Corp (IRIX): R&D Expense

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2017-12-30 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$3.67M
Year ended 2026-01-03, Fiscal 2025
$3.76M
Trailing 12 months to 2026-07-04
-20.0%
3-year compound annual growth
+2.2%
5-year compound annual growth
$7.17M2010-01-02: $3.31M2011-01-01: $3.75M2011-12-31: $3.91M2012-12-29: $4.38M2013-12-28: $3.68M2015-01-03: $4.63M2016-01-02: $5.21M2016-12-31: $5.37M2017-12-30: $5.21M2018-12-29: $4.01M2019-12-28: $3.68M2021-01-02: $3.28M2022-01-01: $6.87M2022-12-31: $7.17M2023-12-30: $6.83M2024-12-28: $5.45M2026-01-03: $3.67M$3.67M
2010-01-02 R&D Expense (USD) 2026-01-03
Period endedR&D ExpenseChange YoYSource filing
2026-01-03, Fiscal 2025$3.67M-32.7%2026-04-02, From 2024-12-29
2024-12-28$5.45M-20.2%2026-04-02, From 2023-12-31
2023-12-30$6.83M-4.8%2025-03-27, From 2023-01-01
2022-12-31$7.17M+4.5%2024-03-29, From 2022-01-02
2022-01-01, Fiscal 2021$6.87M+109.3%2023-03-09, From 2021-01-03
2021-01-02, Fiscal 2020$3.28M-10.9%2022-03-15, From 2019-12-29
2019-12-28$3.68M-8.1%2021-03-23, From 2018-12-30
2018-12-29$4.01M-23.1%2020-03-13, From 2017-12-31
2017-12-30$5.21Mn/c2019-03-29, From 2017-01-01
2016-12-31$5.37M+2.9%2018-03-14, From 2016-01-03
2016-01-02, Fiscal 2015$5.21M+12.6%2018-03-14, From 2015-01-04
2015-01-03, Fiscal 2014$4.63M+25.7%2017-03-15, From 2013-12-29
2013-12-28$3.68M-16.0%2016-03-31, From 2012-12-30
2012-12-29$4.38M+12.1%2015-04-02, From 2012-01-01
2011-12-31$3.91M+4.3%2014-03-27, From 2011-01-02
2011-01-01, Fiscal 2010$3.75M+13.2%2013-03-28, From 2010-01-03
2010-01-02, Fiscal 2009$3.31Mn/a2012-03-30, From 2009-01-04

R&D Expense at similar companies

Companies with the same SEC industry code (Electromedical & Electrotherapeutic Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedR&D ExpenseChange YoY
Iridex Corp (IRIX)2026-01-03$3.67M-32.7%
Electromed, Inc. (ELMD)2026-06-30$1.31M+31.9%
Stereotaxis, Inc. (STXS)2025-12-31$9.38M-3.9%
electroCore, Inc. (ECOR)2024-12-31$2.36M-55.6%
Ceribell, Inc. (CBLL)2025-12-31$19.14M+41.2%
Vaso Corp (VASO)2025-12-31$728.0K-14.5%
Biolife Solutions Inc (BLFS)2025-12-31$7.57M+59.3%
Outset Medical, Inc. (OM)2025-12-31$21.23M-44.7%
Precision Optics Corporation, Inc. (POCI)2025-06-30$1.16M+17.9%

Compare IRIX, ELMD, STXS, ECOR side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗